PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
66.40%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
14.38%
Similar cost growth to VET's 19.05%. Walter Schloss would investigate if industry cost pressures are temporary.
139.84%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
44.14%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-12.74%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
110.71%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-6.63%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
3.76%
Total costs growth 50-75% of VET's 5.93%. Bruce Berkowitz would examine efficiency.
13.79%
Interest expense growth above 1.5x VET's 2.81%. Michael Burry would check for over-leverage.
41.11%
D&A growth above 1.5x VET's 4.01%. Michael Burry would check for excessive investment.
581.44%
EBITDA growth while VET declines. John Neff would investigate advantages.
435.08%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
337.00%
Operating income growth while VET declines. John Neff would investigate advantages.
242.43%
Operating margin growth while VET declines. John Neff would investigate advantages.
48.10%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
262.42%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
197.61%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
363.93%
Tax expense growth above 1.5x VET's 9.74%. Michael Burry would check for concerning trends.
237.14%
Net income growth while VET declines. John Neff would investigate advantages.
182.42%
Net margin growth while VET declines. John Neff would investigate advantages.
222.00%
EPS growth while VET declines. John Neff would investigate advantages.
222.00%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
13.06%
Share count reduction below 50% of VET's 1.24%. Michael Burry would check for concerns.
13.06%
Diluted share reduction below 50% of VET's 1.48%. Michael Burry would check for concerns.